Literature DB >> 14639417

Pseudoporphyria associated with hemodialysis treated with N-acetylcysteine.

Jean-François Tremblay, Bertrand Veilleux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14639417     DOI： 10.1016/s0190-9622(03)00893-4

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

1.  Porphyria or not porphyria - that is the question...

Authors:  A Smyth; L Redahan; C Wall; G J Mellotte
Journal:  BMJ Case Rep       Date:  2010-09-20

Review 2.  [Dialysis associated skin changes].

Authors:  H Ulrich; M Landthaler; U Hohenleutner
Journal:  Hautarzt       Date:  2004-05       Impact factor: 0.751

3.  Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis.

Authors:  Susanne G Schäd; Andrea Kraus; Imme Haubitz; Jiri Trcka; Henning Hamm; Hermann J Girschick
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

4.  Drug induced pseudoporphyria in CKD: A case report.

Authors:  S Quaiser; R Khan; A S Khan
Journal:  Indian J Nephrol       Date:  2015 Sep-Oct

5.  Pseudoporphyria associated with nonhemodialyzed renal insufficiency, successfully treated with oral N-acetylcysteine.

Authors:  A C Katoulis; D Ferra; E Toumbis; E Papadavid; A Kanelleas; I Panayiotides; D Rigopoulos
Journal:  Case Rep Dermatol Med       Date:  2013-04-10

6.  "Pseudo" Nomenclature in Dermatology: What's in a Name?

Authors:  Sangita Ghosh; Vijay Kumar Jain
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.